pharma-company /Medicinal products /Active ingredients

Rx · PZN 19449464

OYAVAS 25 mg/ml concentrate for preparation of a solution for infusion 400mg-16ml HU

German trade nameOYAVAS 25 mg-ml Konzentrat zur Herstellung einer Infusionslösung 400mg-16ml HU

Active ingredientBevacizumabPharmaceutical formConcentrate for solution for infusion

According to the data available to us: no longer marketed

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €974

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for OYAVAS 25 mg/ml concentrate for preparation of a solution for infusion 400mg-16ml HU.

Review purchasing terms

OYAVAS 25 mg/ml concentrate for preparation of a solution for infusion 400mg-16ml HU contains the active ingredient Bevacizumab and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 19449464). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.


According to the data available to us, OYAVAS 25 mg/ml concentrate for preparation of a solution for infusion 400mg-16ml HU is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.